SuperworthArcutis Biotherapeutics shares outstanding ARQT
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 135.9M
- On a year earlier
- +7.0%
- more shares
Arcutis Biotherapeutics had 135.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 7.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 128.3M | +3% |
| FY2024 | 124.9M | +35% |
| FY2023 | 92.6M | +52% |
| FY2022 | 61M | +21% |
| FY2021 | 50.2M | +17% |
| FY2020 | 43M | +1995% |
| FY2019 | 2.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 135.9M | +7% | |
| Q1 FY26 | 129.4M | +3% | |
| Q4 FY25 | 128.3M | +3% | |
| Q3 FY25 | 132.9M | +7% | |
| Q2 FY25 | 127M | +3% | |
| Q1 FY25 | 126M | +13% | |
| Q4 FY24 | 124.9M | +35% | |
| Q3 FY24 | 124.3M | +101% | |
| Q2 FY24 | 123.5M | +101% | |
| Q1 FY24 | 111M | +82% | |
| Q4 FY23 | 92.6M | +52% | |
| Q3 FY23 | 61.7M | +8% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Arcutis Biotherapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.